Mississauga, ON Canada and Sacramento, CA USA (July 2, 2020) -Bee Vectoring Technologies International Inc. (the "Company" or "BVT") (TSXV: BEE)(OTCQB: BEVVF) (CVE:BEE) today announced that the European Patent Office (EPO) has granted a patent for BVT`s Clonostachys rosea CR-7 microbial strain (CR-7), and there has been no opposition filed in the nine month post-grant window which has now closed. This patent claims the usefulness of CR-7 as a plant treatment, thus protecting a critical component of BVT`s proprietary natural precision agriculture system, and has been further validated in 14 European countries (Belgium, Germany, Spain, France, UK, Greece, Italy, Poland,...
|
